Retracted: Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer

Detalles Bibliográficos
Autor principal: Healthcare Engineering, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533304/
https://www.ncbi.nlm.nih.gov/pubmed/37771993
http://dx.doi.org/10.1155/2023/9786329
_version_ 1785112163502784512
author Healthcare Engineering, Journal of
author_facet Healthcare Engineering, Journal of
author_sort Healthcare Engineering, Journal of
collection PubMed
description
format Online
Article
Text
id pubmed-10533304
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105333042023-09-28 Retracted: Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer Healthcare Engineering, Journal of J Healthc Eng Retraction Hindawi 2023-09-20 /pmc/articles/PMC10533304/ /pubmed/37771993 http://dx.doi.org/10.1155/2023/9786329 Text en Copyright © 2023 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Healthcare Engineering, Journal of
Retracted: Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer
title Retracted: Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer
title_full Retracted: Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer
title_fullStr Retracted: Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer
title_full_unstemmed Retracted: Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer
title_short Retracted: Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble IL-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid Cancer
title_sort retracted: clinical application value of high-frequency ultrasound combined with detection of serum high mobility group box 1, soluble il-2 receptor, and thyroglobulin antibody in diagnosing thyroid cancer
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533304/
https://www.ncbi.nlm.nih.gov/pubmed/37771993
http://dx.doi.org/10.1155/2023/9786329
work_keys_str_mv AT healthcareengineeringjournalof retractedclinicalapplicationvalueofhighfrequencyultrasoundcombinedwithdetectionofserumhighmobilitygroupbox1solubleil2receptorandthyroglobulinantibodyindiagnosingthyroidcancer

Ejemplares similares